SCHEMBL25326007

SCHEMBL25326007

C[C@@H]1CNC(c2ccc(F)c(Cl)c2)CN1C(=O)C1(C(F)(F)F)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 7/20 0.36
PSEN2 P49810 7/20 0.36
APH1B Q8WW43 7/20 0.36
NCSTN Q92542 7/20 0.36
APH1A Q96BI3 7/20 0.36
PSENEN Q9NZ42 7/20 0.36
PRKAG1 P54619 1/20 0.36
PRKAA1 Q13131 1/20 0.36
PRKAB1 Q9Y478 1/20 0.36
SLC6A2 P23975 2/20 0.34
CYP2D6 P10635 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
KCNH2 Q12809 1/20 0.34
TACR3 P29371 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
RORC P51449 1/20 0.32
ADAMTS5 Q9UNA0 3/20 0.32
MGLL Q99685 2/20 0.31
MMP2 P08253 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25917025 1.00 PSEN1 (0.36) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL30522939 1.00 PSEN1 (0.36) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL30522892 1.00 PSEN1 (0.36) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL25325877 1.00 PSEN1 (0.36) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL30523001 0.92 SLC6A2 (0.35) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL25326485 0.92 SLC6A2 (0.35) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL25327793 0.91 PSEN1 (0.34) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL30523066 0.91 PSEN1 (0.34) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL25327423 0.88 PSEN1 (0.37) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL25327222 0.88 PSEN1 (0.37) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250282749-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2025-09-11 US disclosed
WO-2023146991-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 WO disclosed
WO-2023146991-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250282749-A1 COMPOUNDS AND METHODS OF USE CYP1B1, CYP2C19, UGT1A1 PSEN1 1675/4885PSEN2 1683/4885APH1B 1331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.